![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-023-01569-4/MediaObjects/41440_2023_1569_Fig1_HTML.png)
glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]
Description
[DOI] [PubMed] [Google Scholar] 426.Rankovic Z., Brust T.F., Bohn L.M
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
ArticlePubMed 55
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-025-02418-2/MediaObjects/41440_2025_2418_Figa_HTML.png)
Its signaling helps protect cartilage by reducing cell death, lowering inflammation, and preserving the joint's structure [82]
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62cf/11771532/230a7d42de0e/cureus-0016-00000076519-i03.jpg)
doi: 10.3389/fendo.2021.645563 [DOI] [PMC free article] [PubMed] [Google Scholar] 25
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S2095177923002903-ga1.jpg)
Raccah, D., Gourdy, P., Sagnard, L
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://www.viveagelessweightloss.com/wp-content/uploads/2025/04/glp-1-ig-mobile.jpg)
To sum up, EX can reduce the weight of diabetic patients with or without obesity, and it can also reduce the weight of simple obesity and polycystic ovary syndrome/metabolic syndrome with obesity
![glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/medicina/medicina-60-02030/article_deploy/html/images/medicina-60-02030-g001.png)
